netFormulary Birmingham, Sandwell, Solihull and environs APC Formulary NHS
Maintained by Midlands and Lancashire Commissioning Support Unit  
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Chapter
Notes:

For the most up to date list of agents funded by the Cancer Drugs Fund, please see Cancer Drug Fund list

 Details...
08.03.04.02  Expand sub section  Prostate cancer and gonadorelin analogues
08.03.04.02  Expand sub section  Gonadorelin analogues
08.03.04.02  Expand sub section  Anti-androgens
Abiraterone (Zytiga®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
Cancer Drugs Fund
 
Link  NICE TA259: Abiraterone for castration resistant prostate cancer
Link  NICE TA387: Abiraterone for metastatic hormone-relapsed prostate cancer before chemotherapy
   
Bicalutamide
(tablets)
View adult BNF View SPC online View childrens BNF
Formulary
Amber
 
   
Buserelin
(nasal spray)
View adult BNF View SPC online View childrens BNF
Formulary
Red
  • Listed in Chapter 6 for other indications 
  •    
    Cyproterone Acetate
    (tablets)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
     
       
    Enzalutamide (Xtandi®)
    View adult BNF View SPC online View childrens BNF
    Restricted Drug Restricted
    Red
  • Hospital only- NHSE commissioned
  • In line with NICE and available from day 91 following publication of TA.
     
  • Link  NICE TA377: Metastatic hormone-relapsed prostate cancer before chemotherapy is indicated
       
    Flutamide
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
     
       
    Goserelin (Zoladex®)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
     
       
    Goserelin (Zoladex® LA)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
     
       
    Leuprorelin Acetate (Prostap® 3)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
     
       
    Leuprorelin Acetate (Prostap® SR)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
     
       
    Triptorelin- Decapeptyl® SR
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
  • Accepted on formulary January 2017 following new drug application.
  • cost-effective alternative to current formulary options and a longer administration interval. 
  •    
    08.03.04.02  Expand sub section  Gonadotrophin-releasing hormone antagonists
     ....
     Non Formulary Items
    Triptorelin  (Gonapeptyl Depot®)

    View adult BNF View SPC online View childrens BNF
    Non Formulary
    Black
     
      
    Key
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Unlicensed
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Link to adult BNF
    click to search medicines.org.uk
    Link to children's BNF
    click to search medicines.org.uk
    Link to SPCs
    Cytotoxic Drug
    Cytotoxic Drug
    CD
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHSE
    NHS England
    Homecare
    Homecare
    CCG
    CCG

    Traffic Light Status Information

    Status Description

    Green

    Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications.  

    Amber

    Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate, or initiation and maintenance of prescribing in Primary Care following recommendation from a Specialist.

    Some amber medicines require agreement with the local (internal) medicines committee prior to initiation; others may require a framework to support safe transfer and maintenance of care such as a RICaD or ESCA. The Formulary will be annotated to reflect these requirements.   

    Red

    Medicines for initiation and maintenance prescribing by Specialists only  

    Black

    Non-formulary medicines- medicines not recommended for routine primary care prescribing.  

    Grey

    Positive NICE TA and /or awaiting local clarification on place in therapy ; Please contact your Medicines Optimisation team for more information.  

    netFormulary